China Pharma Holdings, Inc.CPHINYSE
Loading
Year-over-year earnings per share growth rate
Latest
-6.25%
↑ 98% vs avg
Percentile
P49
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-297.12%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -6.25% |
| Q2 2025 | 11.11% |
| Q1 2025 | 30.77% |
| Q4 2024 | -13.04% |
| Q3 2024 | 23.33% |
| Q2 2024 | -50.00% |
| Q1 2024 | 23.08% |
| Q4 2023 | -62.50% |
| Q3 2023 | -33.33% |
| Q2 2023 | -20.00% |
| Q1 2023 | 52.38% |
| Q4 2022 | 73.42% |
| Q3 2022 | -54.90% |
| Q2 2022 | 10.53% |
| Q1 2022 | 10.94% |
| Q4 2021 | -255.56% |
| Q3 2021 | 0.00% |
| Q2 2021 | -5.88% |
| Q1 2021 | 39.29% |
| Q4 2020 | -21.74% |
| Q3 2020 | -7766.67% |
| Q2 2020 | 102.00% |
| Q1 2020 | 96.51% |
| Q4 2019 | -2587.50% |
| Q3 2019 | 15.79% |
| Q2 2019 | -98.12% |
| Q1 2019 | 94.49% |
| Q4 2018 | -304.65% |
| Q3 2018 | -86.96% |
| Q2 2018 | -241.75% |
| Q1 2018 | 97.88% |
| Q4 2017 | -534.00% |
| Q3 2017 | 3.85% |
| Q2 2017 | -136.36% |
| Q1 2017 | 72.15% |
| Q4 2016 | -97.50% |
| Q3 2016 | 28.57% |
| Q2 2016 | -55.56% |
| Q1 2016 | 74.83% |
| Q4 2015 | -313.43% |